Literature DB >> 4205506

Serum levels of C1q, C1r and C1s in normal and pathologic sera.

M M De Bracco, J A Manni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4205506     DOI： 10.1002/art.1780170204

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  5 in total

1.  Collagen-binding microbial surface components recognizing adhesive matrix molecule (MSCRAMM) of Gram-positive bacteria inhibit complement activation via the classical pathway.

Authors:  Mingsong Kang; Ya-Ping Ko; Xiaowen Liang; Caná L Ross; Qing Liu; Barbara E Murray; Magnus Höök
Journal:  J Biol Chem       Date:  2013-05-29       Impact factor: 5.157

2.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

3.  Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2.

Authors:  Z Chen; S B Koralov; G Kelsoe
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307

4.  Demonstration and quantitation of activation of the first component of complement in human serum.

Authors:  R J Ziccardi; N R Cooper
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

5.  EDTA/gelatin zymography method to identify C1s versus activated MMP-9 in plasma and immune complexes of patients with systemic lupus erythematosus.

Authors:  Estefania Ugarte-Berzal; Erik Martens; Lise Boon; Jennifer Vandooren; Daniel Blockmans; Paul Proost; Ghislain Opdenakker
Journal:  J Cell Mol Med       Date:  2018-10-24       Impact factor: 5.310
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.